Precision medicine and schizophrenia: Pitfalls, promises, and policy implications

Schizophrenia, a chronic mental illness impacting thoughts, emotions, and behavior, currently lacks personalized treatment plans. This paper explores how precision medicine, leveraging advancements in pharmacogenetics, artificial intelligence, and neuroscience, can revolutionize diagnosis and improve outcomes for patients with this disorder. While promising, there are challenges and policy implications that emerge from a precision medicine approach, including legal issues related to data privacy and equitable access to treatment plans. This framework offers a realistic path forward for personalized care in schizophrenia, potentially leading to improved management of symptoms and better quality of life for patients.